Phoenix Biotech Acquisition Corp. Class A Common Stock is a leading biotechnology company that specializes in developing innovative treatments for various diseases. With a focus on research and development, the company constantly strives to improve the lives of patients and contribute to the advancement of medical science. Their commitment to excellence and dedication to improving healthcare sets them apart in the industry.